SILENT CEREBRAL INFARCTION IN PATIENTS ENROLLED IN THE TOAST STUDY

Authors
DAVIS PH CLARKE WR BENDIXEN BH ADAMS HP WOOLSON RF CULEBRAS A JACOBY MR GOMEZ FJ HUGHES B DYKEN ME UC EY WOJCIESZEK JM KAPPELLE LJ TANNA AB MITCHELL VL KING MK BRUNO A LAKIND ED JEFFREY DR MLADINICH EK IQBAL J REINERS M BARRETT DW SHIBUYA D WILLIAMS JK RUSSELL P CHAPIN JE AHMED W CARTER S JEFFRIES L KARANJIA PM MADDEN KP RUGGLES KH MICKEL SF GOTTSCHALK PG HANSOTIA PL SORENSON RW JACOBSON DM HINER BC MANCL K LUKASIK E BURCH CM GOMEZ CR MALKOFF MD TULYAPRONCHOTE R SAUER CM RIAZ G SCHMIDT JG MALIK MM VIVESCASTRO LR CRUZFLORES S THOMPSON DW BANET GA JACKSON CM ROTHROCK JF LYDEN PD BRODY ML ZWEIFLER RM TOM T FORDE G KELLY NM HELGASON CM HIER DB SHAPIRO RA BRINT SU GNUTEK T HOFF J OCONNELL D FISHER MJ AMERISO SF GARABEDIAN MH MACKO RF HANNA M YEGYAN GA PARK SJU MARTIN A SCICLI A LIBMAN RB KWIATKOWSKI TG KANNER RM WIRKOWSKI EJ ABRAMS R DONNARUMA R CULLEN V ROSENBAUM DM SPARR SA KATZ PM VALENCIA AM KLONOWSKI E GORDON DL THIEL AA FREDERICKS RK SINGH R RAFIQUE A DENDINGER J GORELICK PB RISKIN BJ MIRZA DB KELLY MA BIJARI A MURRAY JC CURTIN J BOZZOLA FG KOFMAN JC PAJEAU AK SHANMUGAM V AGNELLODIMITRIJEVIC W BROWN N DOLLEAR WC WEINBERGER JM TUHRIM S RUDOLPH SH HOROWITZ DR SHEINART KF GONDOLO TM ALI J BITTON A FELDMANN E WILTERDINK JL FURIE K BALDWIN E RICKS L CAREY GC MARTIR NM KENT PF RABIEE H GUEVARA RA BANGCO MS SHAH K ATTARIAN H PASTOR D FICARRA C MOHR JP SACCO RL CLAVIJO M BILLER J SAVER JL FRANK JI PATRICK JT FERNANDEZBEER E BYER JA WHITE HH SUNDRANI S ZAFAR MJ ARORA R GAMBOA EC STACY M BONNETT A KELLEY C COULL BM BRILEY DP CLARK WM KENNY C AUSTIN T DEGARMO PL ANDERSON DC TARREL RM NANCE MA BUNDLIE SR DOYLE JJ DIERICH M LOVE BB STRUCK LK MUELLER C HOGAN EL CARTER TD GURECKI P PLYER JW MUNTZPOPE BK HOLLANDER J HONCH GW LESSER HD WEBER C WROBEL CJ LERAMO OB BUXTON S FAYAD PB BRASS LM PAVALKIS FJ DUROCHER A PASCUZZI RM POURMAND R REDDY VR CHADWICK LR WARACH SJ MAYMAN CI DARBY DG DASHE JF TIJERINA ML MANDELBAUM MA HASSAN RU ABBAS DH OLMSTEAD CG SEDLACEK L MILLER AE KEILSON MJ BRUINING KM DREXLER EE MORGANTE L RAMIREZLASSEPAS M TULLOCH JW QUINONES MR CLAVEL A MENDEZ MF ZHANG S ALA TA ESPINOSA C JOHNSTON KL HWANG TL BRANNON WL TRUJILLANO AC FRANK RL KASE CS WOLF PA BABIKIAN VL LICATAGEHR EE ALLEN NC CHATURVEDI S CHAPPIDI PV TVARDEK L HOMER D NEELY S CARPENTER J FUTRELL NN WANG D DAVIS KA KORSNACK AM BASSAM BA CUNNINGHAM S DRINKARD R SAVER JL STARKMAN S HOROWITZ SH LAVA NS MANNING M LOVE BB GRIMSMAN KJ OLSON JD PENNELL BJ JOHNSON K CORNELL SH CROSBY DL SIMONSON TM KRUMBHOLZ V COMINE JA ZALESKY CR WASEK PA DIELEMAN JA PAULSEN JM BOREEN JP JONES MF ROBB BM OBERBROECKLING LA HANSEN MD HICKLIN KM FRANKOWSKI RF GREENBERG CS HARKER LA WHISNANT JP FINCHAM RW KISKER TC WALLACE RB
Citation
Ph. Davis et al., SILENT CEREBRAL INFARCTION IN PATIENTS ENROLLED IN THE TOAST STUDY, Neurology, 46(4), 1996, pp. 942-948
Citations number
22
Categorie Soggetti
Clinical Neurology
Journal title
ISSN journal
00283878
Volume
46
Issue
4
Year of publication
1996
Pages
942 - 948
Database
ISI
SICI code
0028-3878(1996)46:4<942:SCIIPE>2.0.ZU;2-N
Abstract
To determine the frequency, location, size, and risk factors for silen t cerebral infarctions (SCIs) on brain CT, we identified 629 patients without a history of previous stroke who were enrolled in a multicente r clinical trial of therapy for acute ischemic stroke. On the baseline CT, 143 patients (22.7%) had SCIs; 34.3% of the lesions were in the r ight hemisphere, 38.5% in the left hemisphere, and 27.3% were bilatera l. The lesion size was <1 cm in 65.7%, and the most common site was th e basal ganglia (48.3%). Patients with SCI were compared with controls without SCI to determine the odds ratios (ORs) for each risk factor. On univariate analysis, race (black versus white) had an OR of 1.80 (9 5% confidence interval [CI], 1.14 to 2.85), male sex an OR of 1.68 (95 % CI, 1.12 to 2.51), and congestive heart failure an OR of 1.88 (95% C I, 1.07 to 3.31). Significant risk factors on multivariate analysis in clude age (OR 1.03 per year, p = 0.0070), male sex (OR 1.78, p = 0.009 4), and race (OR 2.43, p = 0.0004). After including interaction terms with age and hypertension and age, sex, and race, hypertension was als o a significant risk factor.